Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
Apple Announces New M3 Chips
Apple's latest event announced new Mac products and new chips and the company's latest line of Macbook Pros and iMacs were unveiled.
Load More